does retatrutide go bad for weight loss: Study shows 30% body weight loss Retatrutide, an experimental weight-loss drug,

The addition of glucagon produced approximately 25-30% more weight loss than dual agonism

Because direct human data on retatrutide and alcohol is still limited, it is best to be cautious

This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimers disease, liver disease, PCOS, and more

No phone or Wi-Fi setup

Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss

Heres my honest take